PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1453903
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1453903
Pulmonary Valve Replacement Market Forecasts to 2030 - Global Analysis By Valve Type, Procedure Type, Application, End User, and By Geography
According to Stratistics MRC, the Global Pulmonary Valve Replacement Market is accounted for $1.2 billion in 2023 and is expected to reach $2.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Pulmonary valve replacement (PVR) is a surgical procedure aimed at replacing a defective or damaged pulmonary valve in the heart. The pulmonary valve regulates blood flow from the heart's right ventricle to the pulmonary artery, facilitating oxygenation of blood in the lungs. Surgeons typically use either mechanical or biological prosthetic valves to restore proper cardiac function. PVR can alleviate symptoms like shortness of breath, chest pain, and fatigue, improving overall heart health and quality of life. Post-operative care involves monitoring for complications and cardiac rehabilitation to support recovery and long-term well-being.
Market Dynamics:
Driver:
Increasing healthcare expenditure
As healthcare spending rises, particularly in emerging economies and developed countries, there is a corresponding increase in access to specialized cardiac care procedures. This improved infrastructure enables healthcare providers to offer a wider range of treatment options to a greater number of patients. Moreover, increased healthcare spending often correlates with improvements in insurance coverage and reimbursement policies, reducing financial barriers for patients, which drives this market growth.
Restraint:
High cost
The complexity and invasiveness of the procedure are two of the primary factors contributing to the high cost of pulmonary valve replacement. These factors contribute to the overall cost of the procedure, including pre-operative assessments, post-operative care, and follow-up visits. Additionally, the materials used in pulmonary valve replacement, such as prosthetic valves or conduits, can be expensive, further driving up the cost of the procedure.
Opportunity:
Technological advancements
Advancements in prosthetic valve design and materials contribute to improved longevity, durability, and biocompatibility of pulmonary valve replacements. These innovations result in better clinical outcomes and reduced rates of valve failure, leading to increased patient satisfaction and a decreased need for repeat interventions. Furthermore, advancements in imaging technologies, such as 3D echocardiography and cardiac magnetic resonance imaging (MRI), enhance preoperative planning, which is boosting this market growth.
Threat:
Lack of awareness
Limited awareness about the symptoms and consequences of pulmonary valve conditions may lead to delays in diagnosis and intervention, resulting in poorer patient outcomes. Healthcare providers may also lack sufficient understanding of the latest advancements in techniques and technologies, leading to suboptimal patient care and the underutilization of appropriate treatments. Furthermore, patients and their families may have misconceptions or fears about surgical procedures, which can impede this market size.
Covid-19 Impact
The COVID-19 pandemic has significantly impacted the pulmonary valve replacement market. As healthcare systems worldwide diverted resources to manage the pandemic, elective procedures, including pulmonary valve replacements, experienced delays and cancellations. This led to a reduction in procedural volumes and revenue for manufacturers and healthcare facilities specializing in cardiac interventions. Moreover, patient reluctance to seek non-urgent medical care due to fear of exposure to the virus further dampened demand for pulmonary valve replacement procedures.
The tissue engineered pulmonary valves segment is expected to be the largest during the forecast period
The tissue engineered pulmonary valves segment is estimated to hold the largest share. These valves are designed to mimic the structure and function of native pulmonary valves, offering promising solutions for patients with pulmonary valve dysfunction. Tissue-engineered pulmonary valves are typically created by seeding cells onto a biodegradable scaffold, allowing for the growth of living tissue. Additionally, tissue-engineered valves have shown promising outcomes in terms of long-term functionality and hemodynamic performance, which gradually boosts this segment's growth.
The transcatheter pulmonary valve replacement (TPVR) segment is expected to have the highest CAGR during the forecast period
The transcatheter pulmonary valve replacement (TPVR) segment is anticipated to have highest CAGR during the forecast period due to its minimally invasive procedure for replacing pulmonary valves via catheterization. This approach is particularly beneficial for patients with congenital heart defects, pulmonary valve stenosis, or regurgitation. Furthermore, TPVR procedures have demonstrated excellent outcomes in terms of safety, efficacy, and patient recovery, compared to traditional surgical interventions, which are driving this segment's expansion.
Region with largest share:
North America commanded the largest market share during the extrapolated period owing to a growing prevalence of congenital heart diseases and valve disorders. This region is home to some of the major players, such as Medtronic, Abbott Laboratories, and Boston Scientific. Moreover, government initiatives aimed at improving cardiovascular healthcare and advancing medical research also play a vital role in fueling market growth.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period, owing to significant advancements in medical technology, robust healthcare systems. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market's growth in the region. Additionally, Europe has a strong regulatory framework supporting medical innovation, ensuring the safety and efficacy of new pulmonary valve replacement technologies, fostering competition, and driving advancements in the field.
Key players in the market
Some of the key players in the Pulmonary Valve Replacement Market include Edwards Lifesciences, Medtronic, Terumo Corporation, CryoLife, Inc, SynCardia Systems, Inc., Abbott Laboratories, Merit Medical Systems, LivaNova PLC, Micro Interventional Devices, Inc., Boston Scientific, Braile Biomedica, JenaValve Technology, Inc., B. Braun Melsungen AG, Medistim and CardioMech AS.
Key Developments:
In January 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.
In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral(TM) renal denervation (RDN) system, also known as the Symplicity(TM) blood pressure procedure, for the treatment of hypertension.
In September 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX(TM) Pro Left Atrial Appendage Closure (LAAC) Device.
Valve Types Covered:
- Tissue Engineered Pulmonary Valves
- Bioprosthetic Pulmonary Valves
- Homograft Pulmonary Valves
- Mechanical Pulmonary Valves
- Other Valve Types
Procedure Types Covered:
- Transcatheter Pulmonary Valve Replacement (TPVR)
- Surgical Pulmonary Valve Replacement (Open-heart surgery)
- Robotic-Assisted Pulmonary Valve Replacement
- Ross Procedure
- Valvulotomy
- Other Procedure Types
Applications Covered:
- Pulmonary Stenosis
- Valve Dysfunction
- Congenital Heart Defects
- Pulmonary Regurgitation
- Other Applications
End Users Covered:
- Ambulatory Surgical Centers
- Hospitals
- Cardiac Specialty Clinics
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Pulmonary Valve Replacement Market, By Valve Type
- 5.1 Introduction
- 5.2 Tissue Engineered Pulmonary Valves
- 5.3 Bioprosthetic Pulmonary Valves
- 5.4 Homograft Pulmonary Valves
- 5.5 Mechanical Pulmonary Valves
- 5.6 Other Valve Types
6 Global Pulmonary Valve Replacement Market, By Procedure Type
- 6.1 Introduction
- 6.2 Transcatheter Pulmonary Valve Replacement (TPVR)
- 6.3 Surgical Pulmonary Valve Replacement (Open-heart surgery)
- 6.4 Robotic-Assisted Pulmonary Valve Replacement
- 6.5 Ross Procedure
- 6.6 Valvulotomy
- 6.7 Other Procedure Types
7 Global Pulmonary Valve Replacement Market, By Application
- 7.1 Introduction
- 7.2 Pulmonary Stenosis
- 7.3 Valve Dysfunction
- 7.4 Congenital Heart Defects
- 7.5 Pulmonary Regurgitation
- 7.6 Other Applications
8 Global Pulmonary Valve Replacement Market, By End User
- 8.1 Introduction
- 8.2 Ambulatory Surgical Centers
- 8.3 Hospitals
- 8.4 Cardiac Specialty Clinics
- 8.5 Other End Users
9 Global Pulmonary Valve Replacement Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Edwards Lifesciences
- 11.2 Medtronic
- 11.3 Terumo Corporation
- 11.4 CryoLife, Inc
- 11.5 SynCardia Systems, Inc.
- 11.6 Abbott Laboratories
- 11.7 Merit Medical Systems
- 11.8 LivaNova PLC
- 11.9 Micro Interventional Devices, Inc.
- 11.10 Boston Scientific
- 11.11 Braile Biomedica
- 11.12 JenaValve Technology, Inc.
- 11.13 B. Braun Melsungen AG
- 11.14 Medistim
- 11.15 CardioMech AS
List of Tables
- Table 1 Global Pulmonary Valve Replacement Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
- Table 3 Global Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
- Table 4 Global Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
- Table 5 Global Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
- Table 6 Global Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
- Table 7 Global Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
- Table 8 Global Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
- Table 9 Global Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
- Table 10 Global Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
- Table 11 Global Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
- Table 12 Global Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
- Table 13 Global Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
- Table 14 Global Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
- Table 15 Global Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
- Table 16 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
- Table 17 Global Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
- Table 18 Global Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
- Table 19 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
- Table 20 Global Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 21 Global Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
- Table 22 Global Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 23 Global Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 24 Global Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
- Table 25 Global Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 26 North America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
- Table 27 North America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
- Table 28 North America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
- Table 29 North America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
- Table 30 North America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
- Table 31 North America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
- Table 32 North America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
- Table 33 North America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
- Table 34 North America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
- Table 35 North America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
- Table 36 North America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
- Table 37 North America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
- Table 38 North America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
- Table 39 North America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
- Table 40 North America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
- Table 41 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
- Table 42 North America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
- Table 43 North America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
- Table 44 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
- Table 45 North America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 46 North America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
- Table 47 North America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 48 North America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 49 North America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
- Table 50 North America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 51 Europe Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
- Table 52 Europe Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
- Table 53 Europe Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
- Table 54 Europe Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
- Table 55 Europe Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
- Table 56 Europe Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
- Table 57 Europe Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
- Table 58 Europe Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
- Table 59 Europe Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
- Table 60 Europe Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
- Table 61 Europe Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
- Table 62 Europe Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
- Table 63 Europe Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
- Table 64 Europe Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
- Table 65 Europe Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
- Table 66 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
- Table 67 Europe Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
- Table 68 Europe Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
- Table 69 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
- Table 70 Europe Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 71 Europe Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
- Table 72 Europe Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 73 Europe Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 74 Europe Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
- Table 75 Europe Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 76 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
- Table 77 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
- Table 78 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
- Table 79 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
- Table 80 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
- Table 81 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
- Table 82 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
- Table 83 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
- Table 84 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
- Table 85 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
- Table 86 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
- Table 87 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
- Table 88 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
- Table 89 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
- Table 90 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
- Table 91 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
- Table 92 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
- Table 93 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
- Table 94 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
- Table 95 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 96 Asia Pacific Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
- Table 97 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 98 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 99 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
- Table 100 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 101 South America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
- Table 102 South America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
- Table 103 South America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
- Table 104 South America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
- Table 105 South America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
- Table 106 South America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
- Table 107 South America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
- Table 108 South America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
- Table 109 South America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
- Table 110 South America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
- Table 111 South America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
- Table 112 South America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
- Table 113 South America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
- Table 114 South America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
- Table 115 South America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
- Table 116 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
- Table 117 South America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
- Table 118 South America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
- Table 119 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
- Table 120 South America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 121 South America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
- Table 122 South America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 123 South America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 124 South America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
- Table 125 South America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 126 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
- Table 127 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
- Table 128 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
- Table 129 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
- Table 130 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
- Table 131 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
- Table 132 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
- Table 133 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
- Table 134 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
- Table 135 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
- Table 136 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
- Table 137 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
- Table 138 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
- Table 139 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
- Table 140 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
- Table 141 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
- Table 142 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
- Table 143 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
- Table 144 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
- Table 145 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 146 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
- Table 147 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 148 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 149 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
- Table 150 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
